Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Specialty Chemicals

Clean Science and Technology Limited, research, develops, manufactures, and markets specialty chemicals in India and internationally. The company operates through Performance Chemicals, FMCG Chemicals, and Pharma & Agro Intermediates segments. It also offers FMCG Chemicals, including anisole, guaiacol, 4-methoxy acetophenone, butylated hydroxy anisole, veratrole, L-ascorbyl palmitate, tertiary butyl hydroquinone, ortho methoxy toluene, and para di-methoxy benzene (1,4-DMB). In addition, the company offers performance chemicals comprising clean light stab 770, 4-hydroxy tempo, mono methyl ether of hydroquinone, butylated hydroxy anisole, L-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, tertiary butyl hydroquinone, and dimethyl sebacate. Further, it provides pharma and agro intermediates, such as dicyclohexylcarbodimide, veratrole, para benzoquinone, and para di-methoxy benzene (1,4-DMB). Clean Science and Technology Limited serves food and infant food formulations, agricultural chemicals, polymers and monomers, perfumes, cosmetic, and other sectors. The company was incorporated in 2003 and is based in Pune, India.

Revenue projections:

Revenue projections for CLEAN
Revenue projections for CLEAN

Clean Science and Technology Limited's revenues are expected to fall below last year's, and this forecast tends to raise concerns among investors. A revenue drop can negatively impact the company's profitability, making investors more cautious about their positions due to the risks of declining financial performance.

Financial Ratios:

currentRatio 0.00000
forwardPE 30.99151
debtToEquity 0.14200
earningsGrowth -0.30100
revenueGrowth -0.08800
grossMargins 0.61949
operatingMargins 0.24090
trailingEps 23.10000
forwardEps 26.48790

CLEAN's low earnings and revenue growth highlight potential profit shrinkage. This suggests that the company may struggle to maintain its financial performance, raising concerns about its future profitability.
CLEAN's positive gross and operating margins indicate healthy profitability. These margins reflect the company's ability to generate income efficiently from its operations, signaling strong financial performance and effective cost management.
CLEAN's forward EPS surpassing its trailing EPS signals that the company is anticipated to be more profitable this year than last. This growth expectation highlights CLEAN's potential for increased earnings and a stronger financial performance in the upcoming year.

Price projections:

Price projections for CLEAN
Price projections for CLEAN

Price projections for CLEAN have been steadily revised downward over time, indicating growing concerns about the company's future performance. This downward trend reflects reduced optimism among analysts regarding CLEAN's ability to meet previous expectations.

Recommendation changes over time:

Recommendations trend for CLEAN
Recommendations trend for CLEAN


CLEAN has been receiving a buy bias from analysts, indicating confidence in its investment potential. This could drive more investors to view CLEAN as a reliable choice for their money, offering a promising avenue for future growth and financial gains.